ABSTRACT
Nonlinear metasurface holography shows the great potential of metasurfaces to control the phase, amplitude, and polarization of light while simultaneously converting the frequency of the light. The possibility of tailoring the scattering properties of a coherent beam, as well as the scattering properties of nonlinear signals originating from the meta-atoms, facilitates a huge degree of freedom in beam shaping application. Recently, several approaches showed that virtual objects or any kind of optical information can be generated at a wavelength different from the laser input beam. Here, we demonstrate a single-layer nonlinear geometric-phase metasurface made of plasmonic nanostructures for a simultaneous second- and third-harmonic generation. Different from previous works, we demonstrate a two-color hologram with dissimilar types of nanostructures that generate the color information by different nonlinear optical processes. The amplitude ratio of both harmonic signals can be adapted depending on the nanostructures' resonance as well as the power and the wavelength of the incident laser beam. The two-color holographic image is reconstructed in the Fourier space at visible wavelengths with equal amplitudes using a single near-infrared wavelength. Nonlinear holography using multiple nonlinear processes simultaneously provides an alternative path to holographic color display applications, enhanced optical encryption schemes, and multiplexed optical data storage.
ABSTRACT
As flexible optical devices that can manipulate the phase and amplitude of light, metasurfaces would clearly benefit from directional optical properties. However, single layer metasurface systems consisting of two-dimensional nanoparticle arrays exhibit only a weak spatial asymmetry perpendicular to the surface and therefore have mostly symmetric transmission features. Here, we present a metasurface design principle for nonreciprocal polarization encryption of holographic images. Our approach is based on a two-layer plasmonic metasurface design that introduces a local asymmetry and generates a bidirectional functionality with full phase and amplitude control of the transmitted light. The encoded hologram is designed to appear in a particular linear cross-polarization channel, while it is disappearing in the reverse propagation direction. Hence, layered metasurface systems can feature asymmetric transmission with full phase and amplitude control and therefore expand the design freedom in nanoscale optical devices toward asymmetric information processing and security features for anticounterfeiting applications.
ABSTRACT
OBJECTIVE To investigate the effects of dietary supplementation with the ß-adrenoceptor agonists ractopamine hydrochloride and zilpaterol hydrochloride on ECG and clinicopathologic variables of finishing beef steers. DESIGN Randomized controlled trial. ANIMALS 30 Angus steers. PROCEDURES Steers were grouped by body weight and randomly assigned to receive 1 of 3 diets for 23 days: a diet containing no additive (control diet) or a diet containing ractopamine hydrochloride (300 mg/steer/d) or zilpaterol hydrochloride (8.3 mg/kg [3.8 mg/lb] of feed on a dry-matter basis), beginning on day 0. Steers were instrumented with an ambulatory ECG monitor on days -2, 6, 13, and 23, and continuous recordings were obtained for 72, 24, 24, and 96 hours, respectively. At the time of instrumentation, blood samples were obtained for CBC and serum biochemical and blood lactate analysis. Electrocardiographic recordings were evaluated for mean heart rate and arrhythmia rates. RESULTS Steers fed zilpaterol or ractopamine had greater mean heart rates than those fed the control diet. Mean heart rates were within reference limits for all steers, with the exception of those in the ractopamine group on day 14, in which mean heart rate was high. No differences in arrhythmia rates were identified among the groups, nor were any differences identified when arrhythmias were classified as single, paired, or multiple (> 2) beats. CONCLUSIONS AND CLINICAL RELEVANCE Results suggested that dietary supplementation of cattle with ractopamine or zilpaterol at FDA-approved doses had no effect on arrhythmia rates but caused an increase in heart rate that remained within reference limits.
